文献速递心血管MR

COVID-19疫苗相关心肌炎的心脏MRI心肌损伤模式

Myocardial Injury Pattern at MRI in COVID-19 Vaccine-Associated Myocarditis.
PubMed 文献 · Radiology · 2022-02-15

这项回顾性队列研究纳入92例心脏MRI显示至少一项T1及一项T2异常的心肌炎成人患者,其中21例(23%)为COVID-19疫苗接种后心肌炎。MRI显示疫苗相关心肌炎晚期钆增强(LGE)17例(81%)、左心室功能障碍6例(29%),与其他原因心肌炎相比左心室射血分数更高、LGE范围更小、室间隔受累更少,短期随访无不良事件。

要点

  • 疫苗相关心肌炎MRI表现:81%有LGE,29%有左心室功能障碍。
  • LGE最常见部位为基底侧下壁心外膜下,室间隔受累较少见。
  • 与其他心肌炎相比,疫苗相关者左心室射血分数更高、LGE范围更小。

核心结论

  • 心脏MRI显示疫苗相关心肌炎与其他原因心肌炎心肌损伤模式相似,但异常程度较轻、室间隔受累较少,短期随访无不良事件。

研究设计与样本

  • 回顾性队列研究,纳入2019年12月至2021年11月在一家三级转诊医院连续入组的成人心肌炎患者92例,均至少有一项基于T1和一项基于T2的MRI异常;分为COVID-19疫苗接种后心肌炎、COVID-19疾病后心肌炎及其他心肌炎三组。

关键影像表现/征象

  • 疫苗相关心肌炎21例中,晚期钆增强(LGE)17例(81%),左心室功能障碍6例(29%)。
  • 所有组LGE最常见部位为基底侧下壁心外膜下,但室间隔受累在疫苗相关心肌炎中较少见。
  • 与其他原因心肌炎相比,疫苗相关心肌炎患者左心室射血分数更高、LGE范围更小,即使控制年龄、性别及症状出现至MRI时间后仍如此。

诊断标准与关键数值

  • 疫苗相关心肌炎组21例(23%),平均年龄31岁±14(SD),男性17例;mRNA-1273疫苗12例(57%),BNT162b2疫苗9例(43%)。
  • COVID-19疾病后心肌炎组10例(11%),平均年龄51岁±14,男性3例。
  • 其他心肌炎组61例(66%),平均年龄44岁±18,男性36例。

临床应用与阅片要点

  • 疫苗相关心肌炎在MRI上可见基底侧下壁心外膜下LGE,室间隔受累较少,左心室功能多保留。
  • 短期随访(中位22天,IQR 7-48天)所有疫苗相关心肌炎患者无症状且无不良事件。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background There are limited data on the pattern and severity of myocardial injury in patients with COVID-19 vaccination-associated myocarditis. Purpose To describe myocardial injury following COVID-19 vaccination and to compare these findings to other causes of myocarditis. Materials and Methods In this retrospective cohort study, consecutive adult patients with myocarditis with at least one T1-based and at least one T2-based abnormality at cardiac MRI performed at a tertiary referral hospital from December 2019 to November 2021 were included. Patients were classified into one of three groups: myocarditis following COVID-19 vaccination, myocarditis following COVID-19 illness, and other myocarditis not associated with COVID-19 vaccination or illness. Results Of the 92 included patients, 21 (23%) had myocarditis following COVID-19 vaccination (mean age, 31 years ± 14 [SD]; 17 men; messenger RNA-1273 in 12 [57%] and BNT162b2 in nine [43%]). Ten of 92 (11%) patients had myocarditis following COVID-19 illness (mean age, 51 years ± 14; three men) and 61 of 92 (66%) patients had other myocarditis (mean age, 44 years ± 18; 36 men). MRI findings in the 21 patients with vaccine-associated myocarditis included late gadolinium enhancement (LGE) in 17 patients (81%) and left ventricular dysfunction in six (29%). Compared with other causes of myocarditis, patients with vaccine-associated myocarditis had a higher left ventricular ejection fraction and less extensive LGE, even after controlling for age, sex, and time from symptom onset to MRI. The most frequent location of LGE in all groups was subepicardial at the basal inferolateral wall, although septal involvement was less common in vaccine-associated myocarditis. At short-term follow-up (median, 22 days [IQR, 7-48 days]), all patients with vaccine-associated myocarditis were asymptomatic with no adverse events. Conclusion Cardiac MRI demonstrated a similar pattern of myocardial injury in vaccine-associated myocarditis compared with other causes, although abnormalities were less severe, with less frequent septal involvement and no adverse events over the short-term follow-up. © RSNA, 2022 Online supplemental material is available for this article. See also the editorial by Raman and Neubauer in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Fronza, Thavendiranathan, Chan, et al. Myocardial Injury Pattern at MRI in COVID-19 Vaccine-Associated Myocarditis. Radiology. 2022. PMID: 35166587. doi:10.1148/radiol.212559

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。